Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”

Krasic J, Skara L, Bojanac KA, et al. The utility of cfDNA in TGCT patient management: a systematic review. Ther Adv Med Oncol 2022; 14: 1–17. DOI: 10.1177/17588359221090365.

While processing the above-referenced paper, a few of the reference citations in Table 1 were listed incorrectly.

The corrected and updated Table 1 is as given below. The table has been corrected online in the published version of the article.

Table 1.

Studies on cfDNA in TGCT identified by systemic review, as well as studies identified that assessed STM and miR-371a-3p sensitivity and specificity.

ctDNA–TGCT						AFP or bHCG or LDH–TGCT					miR-371a-3p–TGCT
Study		Sensitivity		Specificity		Study	Sensitivity		Specificity		Study	Sensitivity		Specificity
		TGCT	SE	TGCT	SE		TGCT	SE	TGCT	SE		TGCT	SE	TGCT	SE
			NSE		NSE			NSE		NSE			NSE		NSE
Kawakami37	Methylation	64%	71%	100%	100%	Cremerius43	67%		100%		Dieckmann44	67%	85%	100%	100%
			55%		100%								45%		100%
Ellinger38	Methylation	67%	61%	100%	100%	Dieckmann44	38%	23%	100%	100%	Gillis45	89%	85%	61%
			73%		100%			55%		100%			91%
Ellinger40	Concentration	88%	85%	97%	97%	Syring46	46%	36%	92%	92%	Syring46	85%	83%	99%	99%
			91%		94%			67%		92%			89%		99%
	Integrity	57%	60%	89%	87%	Dieckmann81	50%	46%	100%	100%	Agthoven47	89%	89%	90%	90%
			60%		89%			58%		100%			89%		90%
Ellinger39	Mitochondrial conc.	60%	49%	94%	97%	Lobo48	71%	61%	100%	100%	Dieckmann81	88%	86%	93%	93%
			69%		94%			83%		100%			90%		93%
Lobo15	Methylation	87%	91%	100%	100%	Dieckmann49	60%	45%	90%	90%	Dieckmann50	90%	87%	94%	94%
			86%		100%			82%		90%			94%		94%
Tsui (2021)32	Mutation	50%		100%		Dieckmann50	60%				Nappi78	96%		100%
						Mørup (2020)51	62%	44%			Mørup51	68%	53%	100%	100%
								74%					78%		100%
						Badia (2021)52	58%		100%		Badia52	93%		100%
											Lobo15	86%	91%	100%	100%
													84%		100%
											Piao74	90%		85%

cfDNA, cell-free DNA; NSE, non-seminoma; SE, seminoma; AFP, alpha-feto-protein; bHCG, beta human chorionic gonadotropin; LDH, lactate dehydrogenase; TGCT, testicular germ cell tumors.